Indication

Maintenance of healing duodenal ulcer

Maintenance of healing duodenal ulcer refers to the post-acute management phase in patients who have achieved endoscopic re-epithelialization or complete resolution of an active peptic ulcer located in the proximal small intestine. Read more about Maintenance of healing duodenal ulcer

282 drugs 160 manufacturers

Advertisement

Drugs that treat it

Common Maintenance of healing duodenal ulcer therapies.

Showing 235–243 of 282 drugs

FAMOTIDINE

PEPTIC ULCER AGENTS·MULTIPLE ENDOCRINE NEOPLASIA·+13
PRECISION DOSE

FAMOTIDINE

PEPTIC ULCER AGENTS·MULTIPLE ENDOCRINE NEOPLASIA·+13
CAMBER CONSUMER

FAMOTIDINE

PEPTIC ULCER AGENTS·MULTIPLE ENDOCRINE NEOPLASIA·+13
WESTMINSTER PHA

FAMOTIDINE

PEPTIC ULCER AGENTS·MULTIPLE ENDOCRINE NEOPLASIA·+13
BIOCON PHARMA I

FAMOTIDINE

PEPTIC ULCER AGENTS·MULTIPLE ENDOCRINE NEOPLASIA·+13
ZYDUS PHARMACEU

FAMOTIDINE

PEPTIC ULCER AGENTS·MULTIPLE ENDOCRINE NEOPLASIA·+13
LIFESTAR PHARMA

LANSOPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
LIFESTAR PHARMA

FAMOTIDINE

PEPTIC ULCER AGENTS·MULTIPLE ENDOCRINE NEOPLASIA·+13
ATHENEX PHARMAC

FAMOTIDINE

PEPTIC ULCER AGENTS·MULTIPLE ENDOCRINE NEOPLASIA·+13
APHENA PHARMA S
Filter & compare in the drug finder →Opens the drug finder with Maintenance of healing duodenal ulcer preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Maintenance of healing duodenal ulcer.

Maintenance of healing duodenal ulcer refers to the post-acute management phase in patients who have achieved endoscopic re-epithelialization or complete resolution of an active peptic ulcer located in the proximal small intestine.

Duodenal ulcers arise from mucosal breakdown in the duodenal bulb when aggressive factors, primarily gastric acid and pepsin, overwhelm endogenous mucosal defense mechanisms, frequently triggered by persistent *Helicobacter pylori* infection or chronic nonsteroidal anti-inflammatory drug use.

This clinical state focuses on sustained acid suppression or mucosal cytoprotection to prevent lesion recurrence and subsequent complications, such as gastrointestinal hemorrhage, perforation, or gastric outlet obstruction, particularly in individuals with recurrent ulcer disease, incomplete eradication of risk factors, or continued exposure to ulcerogenic agents.

Personalize your experience

Follow Maintenance of healing duodenal ulcer and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it